Addus HomeCare Co. (NASDAQ:ADUS) Stock Holdings Increased by State Street Corp

State Street Corp raised its stake in shares of Addus HomeCare Co. (NASDAQ:ADUS - Free Report) by 4.4% during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 663,610 shares of the company's stock after purchasing an additional 27,990 shares during the quarter. State Street Corp owned approximately 3.66% of Addus HomeCare worth $88,280,000 at the end of the most recent reporting period.

Other large investors have also added to or reduced their stakes in the company. Summit Global Investments boosted its holdings in shares of Addus HomeCare by 7.9% in the 2nd quarter. Summit Global Investments now owns 10,752 shares of the company's stock worth $1,248,000 after purchasing an additional 790 shares during the period. Louisiana State Employees Retirement System lifted its stake in Addus HomeCare by 2.5% in the 2nd quarter. Louisiana State Employees Retirement System now owns 8,100 shares of the company's stock worth $940,000 after purchasing an additional 200 shares in the last quarter. Argent Capital Management LLC raised its stake in Addus HomeCare by 51.5% during the second quarter. Argent Capital Management LLC now owns 37,310 shares of the company's stock worth $4,332,000 after purchasing an additional 12,685 shares during the period. Tributary Capital Management LLC lifted its position in Addus HomeCare by 0.3% in the second quarter. Tributary Capital Management LLC now owns 208,370 shares of the company's stock valued at $24,194,000 after buying an additional 609 shares during the last quarter. Finally, Bank of New York Mellon Corp lifted its stake in Addus HomeCare by 4.8% during the second quarter. Bank of New York Mellon Corp now owns 129,449 shares of the company's stock worth $15,030,000 after purchasing an additional 5,952 shares in the last quarter. Hedge funds and other institutional investors own 95.35% of the company's stock.

Analyst Upgrades and Downgrades

A number of analysts recently issued reports on the company. JMP Securities started coverage on Addus HomeCare in a research report on Monday. They issued an "outperform" rating and a $150.00 target price for the company. Royal Bank of Canada restated an "outperform" rating and set a $136.00 target price on shares of Addus HomeCare in a research report on Thursday, November 14th. Oppenheimer boosted their price objective on shares of Addus HomeCare from $140.00 to $145.00 and gave the stock an "outperform" rating in a research note on Monday, September 23rd. Stephens increased their price target on Addus HomeCare from $143.00 to $145.00 and gave the company an "overweight" rating in a report on Wednesday, November 6th. Finally, Macquarie reiterated an "outperform" rating and set a $139.00 price objective on shares of Addus HomeCare in a research report on Monday, November 4th. One equities research analyst has rated the stock with a sell rating, nine have given a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat.com, Addus HomeCare presently has a consensus rating of "Moderate Buy" and a consensus target price of $133.67.

Addus HomeCare Stock Performance

NASDAQ ADUS traded up $0.32 during trading hours on Tuesday, hitting $130.73. The company had a trading volume of 269,447 shares, compared to its average volume of 132,189. Addus HomeCare Co. has a 52 week low of $85.94 and a 52 week high of $136.12. The firm has a 50 day simple moving average of $125.76 and a 200 day simple moving average of $124.69. The firm has a market capitalization of $2.37 billion, a price-to-earnings ratio of 29.92, a PEG ratio of 2.11 and a beta of 1.01.

Addus HomeCare (NASDAQ:ADUS - Get Free Report) last announced its quarterly earnings results on Monday, November 4th. The company reported $1.30 earnings per share for the quarter, beating the consensus estimate of $1.28 by $0.02. The company had revenue of $289.80 million during the quarter, compared to the consensus estimate of $289.42 million. Addus HomeCare had a net margin of 6.50% and a return on equity of 9.62%. The firm's quarterly revenue was up 7.1% compared to the same quarter last year. During the same quarter last year, the firm earned $1.03 earnings per share. On average, research analysts forecast that Addus HomeCare Co. will post 4.59 earnings per share for the current year.

Insider Transactions at Addus HomeCare

In other Addus HomeCare news, CEO R Dirk Allison sold 12,500 shares of the firm's stock in a transaction on Monday, November 25th. The shares were sold at an average price of $123.16, for a total transaction of $1,539,500.00. Following the transaction, the chief executive officer now directly owns 141,897 shares of the company's stock, valued at approximately $17,476,034.52. This trade represents a 8.10 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Also, EVP Roberton James Stevenson sold 2,250 shares of the firm's stock in a transaction on Monday, December 9th. The stock was sold at an average price of $121.00, for a total value of $272,250.00. Following the transaction, the executive vice president now directly owns 10,217 shares of the company's stock, valued at $1,236,257. The trade was a 18.05 % decrease in their position. The disclosure for this sale can be found here. Corporate insiders own 4.60% of the company's stock.

Addus HomeCare Profile

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.